Fellow awards for ophthalmologists

Article

Three professors from the UCL Institute of Ophthalmology are to become fellows of the Association for Research in Vision and Ophthalmology (ARVO) in its first honours list.

Three professors from the UCL Institute of Ophthalmology are to become fellows of the Association for Research in Vision and Ophthalmology (ARVO) in its first honours list. Professors Gary Rubin, Sue Lightman and Fred Fitzke have been commended for their individual accomplishments, leadership and contributions to ARVO.

Professor Rubin has been confirmed as a gold fellow for his long-standing contribution while Professors Lightman and Fitzke have been confirmed as silver fellows. The association uses a point system to determine the eligibility for designating fellows; members are awarded points for each year of participation in activities such as submitting papers for publication, editing refereed journals, and serving on the ARVO committee board.

Robin Ali, Professor of Human Molecular Genetics at the UCL Institute of Ophthalmology, has also won an Alcon Research Institute Award for his outstanding contribution to advancing eye health.

The award was made in recognition of Professor Ali's work in the development of gene and stem cell therapies for the treatment of retinal disorders. He demonstrated improvement in vision in a patient with an inherited retinal degeneration following gene therapy in a clinical trial in 2008.

Professor Ali was nominated by previous winners of the award. He will receive $200,000 in unrestricted grant money to continue his research into the underlying causes of eye disease and has been invited to present his research at the 2011 Alcon Researcch Institute symposium.

Professor Ali said: “I am honoured to have been recognised by this illustrious group of ophthalmic researchers.”

The Alcon Research Institute supports global advancements in eye health by honoring those who make outstanding research contributions to the vision sciences and providing grants to fund ongoing research. This year six awards were made. The institute is part of Alcon, an international eye care company founded in the USA that produces pharmaceutical and consumer products.Congratulations to all.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
© 2025 MJH Life Sciences

All rights reserved.